Limits...
Limb Differences in the Therapeutic Effects of Complex Decongestive Therapy on Edema, Quality of Life, and Satisfaction in Lymphedema Patients.

Noh S, Hwang JH, Yoon TH, Chang HJ, Chu IH, Kim JH - Ann Rehabil Med (2015)

Bottom Line: There was no significant difference in the volume reductions between the 3 groups.There were no significant differences in all of the measures between PL and LL.SF-36 scores post-CDT did not differ significantly between AL and LL.

View Article: PubMed Central - PubMed

Affiliation: Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ABSTRACT

Objective: To investigate the changing patterns of edema, quality of life (QOL), and patient-satisfaction after complex decongestive therapy (CDT) in three trajectories: arm lymphedema (AL), secondary leg lymphedema (LL) and primary leg lymphedema (PL).

Methods: Candidates for AL (n=35), LL (n=35) and PL (n=14) were identified from prospective databases. The patients were treated with CDT for 2 weeks, and lymphedema volume was measured before and immediately following the therapy. Patients then self-administered home therapy for 3 months and presented for a follow-up visit. The Korean version of Short Form-36 (SF-36) was used to assess QOL, and we administered a study-specific satisfaction survey.

Results: There was no significant difference in the volume reductions between the 3 groups. There were no significant differences in all of the measures between PL and LL. Overall initial QOL was significantly lower in patients with LL than in patients with AL. SF-36 scores post-CDT did not differ significantly between AL and LL. Clinically significant differences were noted between AL and LL in the mean values of the satisfaction survey.

Conclusion: AL, LL, and PL may have different longitudinal courses. We suggest that lower extremity lymphedema patients present more favorable outcomes after CDT with respect to QOL and satisfaction than upper extremity lymphedema patients. Clinicians should approach patients with different therapeutic considerations specific to each type or region of lymphedema before using CDT in clinical practice.

No MeSH data available.


Related in: MedlinePlus

Satisfaction with complex decongestive therapy in patients with lymphedema, based on the study-specific satisfaction survey. **p<0.01, ***p<0.001, p-values were derived from independent t-tests.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4496505&req=5

Figure 3: Satisfaction with complex decongestive therapy in patients with lymphedema, based on the study-specific satisfaction survey. **p<0.01, ***p<0.001, p-values were derived from independent t-tests.

Mentions: Satisfaction scores are reported in Fig. 3. The independent t-test with equivalent variance showed no significant differences between the PL and LL groups. The self-reported satisfaction scores from AL patients were lower than those from LL patients. Although no significant differences in volume reduction were observed between AL and LL, satisfaction was higher in LL patients.


Limb Differences in the Therapeutic Effects of Complex Decongestive Therapy on Edema, Quality of Life, and Satisfaction in Lymphedema Patients.

Noh S, Hwang JH, Yoon TH, Chang HJ, Chu IH, Kim JH - Ann Rehabil Med (2015)

Satisfaction with complex decongestive therapy in patients with lymphedema, based on the study-specific satisfaction survey. **p<0.01, ***p<0.001, p-values were derived from independent t-tests.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4496505&req=5

Figure 3: Satisfaction with complex decongestive therapy in patients with lymphedema, based on the study-specific satisfaction survey. **p<0.01, ***p<0.001, p-values were derived from independent t-tests.
Mentions: Satisfaction scores are reported in Fig. 3. The independent t-test with equivalent variance showed no significant differences between the PL and LL groups. The self-reported satisfaction scores from AL patients were lower than those from LL patients. Although no significant differences in volume reduction were observed between AL and LL, satisfaction was higher in LL patients.

Bottom Line: There was no significant difference in the volume reductions between the 3 groups.There were no significant differences in all of the measures between PL and LL.SF-36 scores post-CDT did not differ significantly between AL and LL.

View Article: PubMed Central - PubMed

Affiliation: Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ABSTRACT

Objective: To investigate the changing patterns of edema, quality of life (QOL), and patient-satisfaction after complex decongestive therapy (CDT) in three trajectories: arm lymphedema (AL), secondary leg lymphedema (LL) and primary leg lymphedema (PL).

Methods: Candidates for AL (n=35), LL (n=35) and PL (n=14) were identified from prospective databases. The patients were treated with CDT for 2 weeks, and lymphedema volume was measured before and immediately following the therapy. Patients then self-administered home therapy for 3 months and presented for a follow-up visit. The Korean version of Short Form-36 (SF-36) was used to assess QOL, and we administered a study-specific satisfaction survey.

Results: There was no significant difference in the volume reductions between the 3 groups. There were no significant differences in all of the measures between PL and LL. Overall initial QOL was significantly lower in patients with LL than in patients with AL. SF-36 scores post-CDT did not differ significantly between AL and LL. Clinically significant differences were noted between AL and LL in the mean values of the satisfaction survey.

Conclusion: AL, LL, and PL may have different longitudinal courses. We suggest that lower extremity lymphedema patients present more favorable outcomes after CDT with respect to QOL and satisfaction than upper extremity lymphedema patients. Clinicians should approach patients with different therapeutic considerations specific to each type or region of lymphedema before using CDT in clinical practice.

No MeSH data available.


Related in: MedlinePlus